|
|
|
|
| LEADER |
01972nam a22002775i 4500 |
| 001 |
000288794 |
| 005 |
20210527094523.0 |
| 007 |
cr nn 008mamaa |
| 008 |
131128s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781627037457
|
| 024 |
7 |
|
|a 10.1007/978-1-62703-745-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Ocular Pharmacology and Toxicology /
|c edited by Brian C. Gilger.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2014.
|
| 300 |
|
|
|a X, 323 p. 90 illus., 54 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Pharmacology and Toxicology,
|
| 505 |
0 |
|
|a Challenges in Ocular Pharmacokinetics, Pharmacodynamics, and Toxicology -- Selection of Appropriate Animal Models in Ocular Research: Ocular Anatomy and Physiology of Common Animal Models -- Challenges and Strategies in Drug Residue Measurement (Bioanalysis) of Ocular Tissues -- Chemistry, Manufacturing, and Control of Ophthalmic Formulations -- ADME and Ocular Therapeutics: Retina -- Compositions, Formulation, Pharmacology, Pharmacokinetics, and Toxicity of Topical, Periocular, and Intravitreal Ophthalmic Drugs -- Sustained-Release Ocular Drug Delivery Systems: Bench to Bedside Development -- The Ophthalmic Examination as It Pertains to General Ocular Toxicology: Basic and Advanced Techniques and Species-Associated Findings -- Study Design and Methodologies for Evaluation of Anti-Glaucoma Drugs -- Study Design and Methodologies for Study of Ocular Medical Devices -- Methodologies for Microscopic Characterization of Ocular Toxicity -- Nanoparticles for Drug and Gene Delivery in Treating Diseases of the Eye.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
|
|a Gilger, Brian C.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|